MARINARI, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 2.333
EU - Europa 359
AS - Asia 170
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
SA - Sud America 4
Totale 2.874
Nazione #
US - Stati Uniti d'America 2.333
CN - Cina 79
UA - Ucraina 69
DE - Germania 64
SG - Singapore 63
IE - Irlanda 49
IT - Italia 44
SE - Svezia 32
GB - Regno Unito 30
FR - Francia 25
RU - Federazione Russa 19
FI - Finlandia 11
KR - Corea 11
IN - India 7
PL - Polonia 7
JP - Giappone 5
AU - Australia 3
EU - Europa 3
BE - Belgio 2
KG - Kirghizistan 2
UZ - Uzbekistan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BR - Brasile 1
CL - Cile 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
EC - Ecuador 1
GR - Grecia 1
HU - Ungheria 1
IL - Israele 1
MD - Moldavia 1
NZ - Nuova Zelanda 1
PE - Perù 1
RO - Romania 1
Totale 2.874
Città #
Houston 413
Wilmington 395
Woodbridge 382
Chandler 191
Ann Arbor 180
Fairfield 155
Ashburn 70
Seattle 63
Jacksonville 56
Singapore 51
Cambridge 49
Dublin 49
Medford 40
New York 36
Beijing 33
Dearborn 31
Lawrence 19
Rome 19
Santa Clara 16
Boardman 11
Zhengzhou 10
Moscow 9
Mülheim 9
Munich 8
Falls Church 7
San Diego 7
Kraków 6
Pune 6
Saint Louis 6
Kunming 5
San Mateo 5
Guangzhou 4
Jinan 4
Menlo Park 4
Mountain View 3
Norwalk 3
Redwood City 3
Santa Maria Nuova 3
Shanghai 3
Brussels 2
Crema 2
Guidonia Montecelio 2
Hefei 2
Hounslow 2
Kilburn 2
London 2
Milan 2
Nanjing 2
Nürnberg 2
St Helens 2
Wuhan 2
Auburn Hills 1
Auckland 1
Bari 1
Boston 1
Chisinau 1
Clearwater 1
Cupertino 1
Esslingen am Neckar 1
Haifa 1
Lima 1
Logan 1
Los Angeles 1
Melbourne 1
Nanchang 1
Nanning 1
Pilis 1
Quito 1
Quzhou 1
Redmond 1
Rock Hill 1
San Francisco 1
Scottsdale 1
Seoul 1
Shenyang 1
Southend 1
São Paulo 1
University Park 1
Vienna 1
Yellow Springs 1
Totale 2.417
Nome #
Increased levels of IL-17 in tear fluid of moderate-to-severe psoriatic patients is reduced by adalimumab therapy 407
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response 404
Anti-LL37 antibodies are present in psoriatic arthritis (PsA) patients: New biomarkers in PsA 275
CXCL4 assembles DNA into liquid crystalline complexes to amplify TLR9-mediated interferon-α production in systemic sclerosis 264
Claudin-1 is a p63 target gene with a crucial role in epithelial development 156
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias 149
Native/citrullinated LL37-specific T-cells help autoantibody production in Systemic Lupus Erythematosus 145
p63 induces key target genes required for epidermal morphogenesis 124
Detection of adalimumab and anti-adalimumab levels by ELISA: clinical considerations 115
RelA/NF-kappa B recruitment on the bax gene promoter antagonizes p73-dependent apoptosis in costimulated T cells 107
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappaB subunits on IL-8 and Bcl-xL gene promoters 106
The p73 gene is an anti-tumoral target of the RAR beta/gamma-selective retinoid tazarotene 105
Developmental factor IRF6 exhibits tumor suppressor activity in squamous cell carcinomas 97
The antimicrobial peptide LL37 is a T-cell autoantigen in psoriasis 95
A p38-dependent pathway regulates DeltaNp63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytes 91
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappa B subunits on IL-8 and Bcl-xL gene promotors 89
Genetic markers predictive of clinical response to biological drugs in psoriasis. 82
Delta Np63 Knockdown Mice: A Mouse Model for AEC Syndrome 78
Next generation sequencing technology to explore anti-inflammatory activity of IKKa in psoriasis 38
Totale 2.927
Categoria #
all - tutte 8.743
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.743


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020667 0 0 45 75 59 88 88 75 61 92 36 48
2020/2021447 29 59 43 57 31 38 59 41 23 22 33 12
2021/2022209 3 18 15 10 9 16 5 14 11 26 17 65
2022/2023378 37 42 33 58 23 74 18 24 41 3 21 4
2023/2024128 18 4 3 3 13 44 4 14 0 3 1 21
2024/2025121 31 61 29 0 0 0 0 0 0 0 0 0
Totale 2.927